SEARCH CONTACT US

ACCESSIBILITY

24/7

Headlines

IAI completes maiden flight of A330 freighter in push into Airbus market

Pax Silica: The new alliances will be built not only on weapons, but on chips, compute and power

“Star Wars became reality”: The Arrow 3 interception that changed missile defense

Israel’s tax revenues are booming. The real budget crisis is still ahead

Buzz

Most popular

Daily

Weekly

1

ServiceNow acquires Israeli AI startup Sweep in deal estimated at hundreds of millions

2

Palo Alto’s CEO invested in the startup his company just bought for $500 million

3

Proofpoint in talks to acquire Israeli cybersecurity company Varonis

4

Wonderful raises $550 million at $5 billion valuation just six months after $2 billion round

5

Upwind raises $300 million, more than doubles valuation to $3.8 billion in five months

EpiPen

4 stories about EpiPen

מטה חברת טבע תרופות

Teva Jumps on NYSE on a Bit of Good News

21.08.19|Hezi Sternlicht

An opioid-abuse lawsuit settlement reached by drugmakers Endo and Allergan Tuesday could bode well for Teva’s legal future, as does the release of an FDA-approved generic version of EpiPen JR

תרופה מזרק אפיפן מיילן אלרגיה

Teva, Mylan Drop on Announcement of Epinephrine Injector Rival

09.12.18|Lilach Baumer

Novartis’ U.S. division Sandoz announced a planned release for early 2019. The company will sell its drug, which lacks the EpiPen’s auto-injector, for $250 a pair out of pocket, compared to Mylan and Teva’s $300

תרופה מזרק אפיפן מיילן אלרגיה

Teva’s Generic EpiPen Now Available in the U.S. in Limited Numbers

28.11.18|Lilach Baumer

In August, the Israel-headquartered drugmaker won approval to market the first generic EpiPen auto-injectors in the U.S.

תלמידים כיתה בית ספר לימודים ילדים

Teva’s EpiPen Won’t Hit U.S. Market in Time for School Year, Report Says

26.08.18|Dror Reich

The Israeli drugmaker received approval for a first generic version of Mylan’s auto-injector earlier this month